Table 1

Quality indicators for the inaugural NGOR module

NumberQuality indicatorData definitions
1Percentage of patients with apparent stage I, II or IIIA OTP cancer who are adequately surgically staged.‘Adequate surgical staging’=where clinically applicable, all of the following procedures were performed:

  • Peritoneal washings (and sent for cytology).

  • Total abdominal hysterectomy and bilateral salpingo-oophorectomy (only in cases where fertility preservation is not a priority).

  • Infra-colic omentectomy or wedge biopsy.

  • Sampling of pelvic lymph nodes.

  • Sampling of para-aortic lymph nodes; and.

  • Appendicectomy (mucinous tumours only).

2Percentage of patients with newly diagnosed OTP cancer who are presented at a multi-disciplinary team meeting during which a treatment plan was made.
3Percentage of patients who receive a histological or cytological confirmation of an OTP cancer diagnosis prior to receiving neoadjuvant chemotherapy.‘Neo-adjuvant’ chemotherapy here indicates any chemotherapy given to the patient prior to any planned debulking procedure (even when the patient did not subsequently undergo surgery for clinical reasons).
4Percentage of women with newly diagnosed OTP cancer who receive first-line chemotherapy that is platinum-based.
5Percentage of patients with advanced OTP cancer undergoing primary debulking surgery.

  1. have optimal debulking to no macroscopic residual cancer, or

  2. have optimal debulking to ≤1 cm macroscopic residual cancer

‘Advanced’=stages IIB, IIIB, IIIC and IV (International Federation of Gynecology and Obstetrics (FIGO) classification)
‘Primary debulking’=debulking surgery performed after 0 cycles of chemotherapy
‘Interval debulking’=debulking surgery performed after 3–4 cycles of chemotherapy
6Percentage of patients with advanced OTP cancer who undergo interval debulking surgery:

  1. Have optimal debulking to no macroscopic residual cancer, or

  2. Have optimal debulking to ≤1 cm macroscopic residual cancer.

7Percentage of major operations for epithelial OTP cancer with an adverse event occurring within 30 days of surgery.Intraoperative complications=blood loss of >2 units or any injury caused during the surgery, to the bladder, ureter, small or large bowel, vascular system or nerve(s).
8Percentage of major operations for epithelial OTP cancer with an adverse event occurring within 30 days of surgery.Where ‘adverse events’ includes:

  • Unplanned return to theatre;

  • Unplanned admission to ICU;

  • Unplanned admission to CCU;

  • Unplanned readmission to hospital;

  • Death;

  • Or one of the following:

  • o Anastomotic leak

  • o Small bowel obstruction

  • o Urinary tract injury

  • o Postoperative haemorrhage

  • o Infection requiring antibiotics

  • o Prolonged ileus (≥7 days)

  • o Peritonitis

  • o Thromboembolism

  • o Pneumonia and/or pneumothorax

  • o Lymphocyst

9Percentage of women with newly diagnosed OTP cancer who receive a referral for, or are offered, genetic testing.

  • CCU, critical care unit; ICU, intensive care unit; NGOR, National Gynae-Oncology Registry; OTP, ovarian, tubal and peritoneal.